Levofloxacin‐induced rhabdomyolysis in a patient on concurrent atorvastatin: Case report and literature review
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Pharmacy and Therapeutics"
DOI: 10.1111/jcpt.13010
Abstract: The combination of HMG‐CoA reductase inhibitors (statins) and fluoroquinolones generally is not considered a significant risk factor for rhabdomyolysis. Rhabdomyolysis is a known risk associated with statin therapy but has seldom been described with fluoroquinolone… read more here.
Keywords: induced rhabdomyolysis; rhabdomyolysis patient; patient concurrent; case ... See more keywords